Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development

Yukiko Miyazaki; Catherin Marin-Mogollon; Takashi Imai; António M. Mendes; Rianne van der Laak; Angelika Sturm; Fiona J.A. Geurten; Shinya Miyazaki; Severine Chevalley-Maurel; Jai Ramesar; Surendra K. Kolli; Hans Kroeze; Roos van Schuijlenburg; Ahmed M. Salman; Brandon K. Wilder; Arturo Reyes-Sandoval; Koen J. Dechering; Miguel Prudêncio; Chris J. Janse; Shahid M. Khan; Blandine Franke-Fayard

doi:10.3389/fcimb.2020.591046

Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development

Yukiko Miyazaki, Catherin Marin-Mogollon, Takashi Imai, António M. Mendes, Rianne van der Laak, Angelika Sturm, Fiona J.A. Geurten, Shinya Miyazaki, Severine Chevalley-Maurel, Jai Ramesar, Surendra K. Kolli, Hans Kroeze, Roos van Schuijlenburg, Ahmed M. Salman, Brandon K. Wilder, Arturo Reyes-Sandoval, Koen J. Dechering, Miguel Prudêncio, Chris J. Janse, Shahid M. KhanBlandine Franke-Fayard

Vaccine and Gene Therapy Institute

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Chimeric rodent malaria parasites with the endogenous circumsporozoite protein (csp) gene replaced with csp from the human parasites Plasmodium falciparum (Pf) and P. vivax (Pv) are used in preclinical evaluation of CSP vaccines. Chimeric rodent parasites expressing PfCSP have also been assessed as whole sporozoite (WSP) vaccines. Comparable chimeric P. falciparum parasites expressing CSP of P. vivax could be used both for clinical evaluation of vaccines targeting PvCSP in controlled human P. falciparum infections and in WSP vaccines targeting P. vivax and P. falciparum. We generated chimeric P. falciparum parasites expressing both PfCSP and PvCSP. These Pf-PvCSP parasites produced sporozoite comparable to wild type P. falciparum parasites and expressed PfCSP and PvCSP on the sporozoite surface. Pf-PvCSP sporozoites infected human hepatocytes and induced antibodies to the repeats of both PfCSP and PvCSP after immunization of mice. These results support the use of Pf-PvCSP sporozoites in studies optimizing vaccines targeting PvCSP.

Original language	English (US)
Article number	591046
Journal	Frontiers in Cellular and Infection Microbiology
Volume	10
DOIs	https://doi.org/10.3389/fcimb.2020.591046
State	Published - Dec 17 2020

Keywords

Plasmodium falciparum
Plasmodium vivax
chimeric parasites
circumsporozoite protein (CSP)
malaria
vaccines

ASJC Scopus subject areas

Microbiology
Immunology
Microbiology (medical)
Infectious Diseases

Access to Document

10.3389/fcimb.2020.591046

Cite this

Miyazaki, Y., Marin-Mogollon, C., Imai, T., Mendes, A. M., van der Laak, R., Sturm, A., Geurten, F. J. A., Miyazaki, S., Chevalley-Maurel, S., Ramesar, J., Kolli, S. K., Kroeze, H., van Schuijlenburg, R., Salman, A. M., Wilder, B. K., Reyes-Sandoval, A., Dechering, K. J., Prudêncio, M., Janse, C. J., ... Franke-Fayard, B. (2020). Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development. Frontiers in Cellular and Infection Microbiology, 10, Article 591046. https://doi.org/10.3389/fcimb.2020.591046

Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development. / Miyazaki, Yukiko; Marin-Mogollon, Catherin; Imai, Takashi et al.
In: Frontiers in Cellular and Infection Microbiology, Vol. 10, 591046, 17.12.2020.

Research output: Contribution to journal › Article › peer-review

Miyazaki, Y, Marin-Mogollon, C, Imai, T, Mendes, AM, van der Laak, R, Sturm, A, Geurten, FJA, Miyazaki, S, Chevalley-Maurel, S, Ramesar, J, Kolli, SK, Kroeze, H, van Schuijlenburg, R, Salman, AM, Wilder, BK, Reyes-Sandoval, A, Dechering, KJ, Prudêncio, M, Janse, CJ, Khan, SM & Franke-Fayard, B 2020, 'Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development', Frontiers in Cellular and Infection Microbiology, vol. 10, 591046. https://doi.org/10.3389/fcimb.2020.591046

@article{42f70278acb74e10b3c087743399299d,

title = "Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development",

abstract = "Chimeric rodent malaria parasites with the endogenous circumsporozoite protein (csp) gene replaced with csp from the human parasites Plasmodium falciparum (Pf) and P. vivax (Pv) are used in preclinical evaluation of CSP vaccines. Chimeric rodent parasites expressing PfCSP have also been assessed as whole sporozoite (WSP) vaccines. Comparable chimeric P. falciparum parasites expressing CSP of P. vivax could be used both for clinical evaluation of vaccines targeting PvCSP in controlled human P. falciparum infections and in WSP vaccines targeting P. vivax and P. falciparum. We generated chimeric P. falciparum parasites expressing both PfCSP and PvCSP. These Pf-PvCSP parasites produced sporozoite comparable to wild type P. falciparum parasites and expressed PfCSP and PvCSP on the sporozoite surface. Pf-PvCSP sporozoites infected human hepatocytes and induced antibodies to the repeats of both PfCSP and PvCSP after immunization of mice. These results support the use of Pf-PvCSP sporozoites in studies optimizing vaccines targeting PvCSP.",

keywords = "Plasmodium falciparum, Plasmodium vivax, chimeric parasites, circumsporozoite protein (CSP), malaria, vaccines",

author = "Yukiko Miyazaki and Catherin Marin-Mogollon and Takashi Imai and Mendes, {Ant{\'o}nio M.} and {van der Laak}, Rianne and Angelika Sturm and Geurten, {Fiona J.A.} and Shinya Miyazaki and Severine Chevalley-Maurel and Jai Ramesar and Kolli, {Surendra K.} and Hans Kroeze and {van Schuijlenburg}, Roos and Salman, {Ahmed M.} and Wilder, {Brandon K.} and Arturo Reyes-Sandoval and Dechering, {Koen J.} and Miguel Prud{\^e}ncio and Janse, {Chris J.} and Khan, {Shahid M.} and Blandine Franke-Fayard",

note = "Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2020 Miyazaki, Marin-Mogollon, Imai, Mendes, van der Laak, Sturm, Geurten, Miyazaki, Chevalley-Maurel, Ramesar, Kolli, Kroeze, van Schuijlenburg, Salman, Wilder, Reyes-Sandoval, Dechering, Prud{\^e}ncio, Janse, Khan and Franke-Fayard.",

year = "2020",

month = dec,

day = "17",

doi = "10.3389/fcimb.2020.591046",

language = "English (US)",

volume = "10",

journal = "Frontiers in Cellular and Infection Microbiology",

issn = "2235-2988",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development

AU - Miyazaki, Yukiko

AU - Marin-Mogollon, Catherin

AU - Imai, Takashi

AU - Mendes, António M.

AU - van der Laak, Rianne

AU - Sturm, Angelika

AU - Geurten, Fiona J.A.

AU - Miyazaki, Shinya

AU - Chevalley-Maurel, Severine

AU - Ramesar, Jai

AU - Kolli, Surendra K.

AU - Kroeze, Hans

AU - van Schuijlenburg, Roos

AU - Salman, Ahmed M.

AU - Wilder, Brandon K.

AU - Reyes-Sandoval, Arturo

AU - Dechering, Koen J.

AU - Prudêncio, Miguel

AU - Janse, Chris J.

AU - Khan, Shahid M.

AU - Franke-Fayard, Blandine

N1 - Publisher Copyright: © Copyright © 2020 Miyazaki, Marin-Mogollon, Imai, Mendes, van der Laak, Sturm, Geurten, Miyazaki, Chevalley-Maurel, Ramesar, Kolli, Kroeze, van Schuijlenburg, Salman, Wilder, Reyes-Sandoval, Dechering, Prudêncio, Janse, Khan and Franke-Fayard.

PY - 2020/12/17

Y1 - 2020/12/17

N2 - Chimeric rodent malaria parasites with the endogenous circumsporozoite protein (csp) gene replaced with csp from the human parasites Plasmodium falciparum (Pf) and P. vivax (Pv) are used in preclinical evaluation of CSP vaccines. Chimeric rodent parasites expressing PfCSP have also been assessed as whole sporozoite (WSP) vaccines. Comparable chimeric P. falciparum parasites expressing CSP of P. vivax could be used both for clinical evaluation of vaccines targeting PvCSP in controlled human P. falciparum infections and in WSP vaccines targeting P. vivax and P. falciparum. We generated chimeric P. falciparum parasites expressing both PfCSP and PvCSP. These Pf-PvCSP parasites produced sporozoite comparable to wild type P. falciparum parasites and expressed PfCSP and PvCSP on the sporozoite surface. Pf-PvCSP sporozoites infected human hepatocytes and induced antibodies to the repeats of both PfCSP and PvCSP after immunization of mice. These results support the use of Pf-PvCSP sporozoites in studies optimizing vaccines targeting PvCSP.

AB - Chimeric rodent malaria parasites with the endogenous circumsporozoite protein (csp) gene replaced with csp from the human parasites Plasmodium falciparum (Pf) and P. vivax (Pv) are used in preclinical evaluation of CSP vaccines. Chimeric rodent parasites expressing PfCSP have also been assessed as whole sporozoite (WSP) vaccines. Comparable chimeric P. falciparum parasites expressing CSP of P. vivax could be used both for clinical evaluation of vaccines targeting PvCSP in controlled human P. falciparum infections and in WSP vaccines targeting P. vivax and P. falciparum. We generated chimeric P. falciparum parasites expressing both PfCSP and PvCSP. These Pf-PvCSP parasites produced sporozoite comparable to wild type P. falciparum parasites and expressed PfCSP and PvCSP on the sporozoite surface. Pf-PvCSP sporozoites infected human hepatocytes and induced antibodies to the repeats of both PfCSP and PvCSP after immunization of mice. These results support the use of Pf-PvCSP sporozoites in studies optimizing vaccines targeting PvCSP.

KW - Plasmodium falciparum

KW - Plasmodium vivax

KW - chimeric parasites

KW - circumsporozoite protein (CSP)

KW - malaria

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=85098653434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098653434&partnerID=8YFLogxK

U2 - 10.3389/fcimb.2020.591046

DO - 10.3389/fcimb.2020.591046

M3 - Article

C2 - 33392104

AN - SCOPUS:85098653434

SN - 2235-2988

VL - 10

JO - Frontiers in Cellular and Infection Microbiology

JF - Frontiers in Cellular and Infection Microbiology

M1 - 591046

ER -